J&J offers $5.5bn settlement in lawsuits claiming talc link to cancer
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 69,000 lawsuits alleging that its talc-based baby powder caused ovarian cancer. The company maintains its products are safe but seeks to end years of litigation, excluding ongoing cases in the UK.
Why it matters
This settlement represents a major resolution to a long-standing legal battle regarding product safety and corporate liability in the pharmaceutical industry.
Settlement resolves thousands of US lawsuits, with a record UK case against the company under way.
x whatsapp-stroke copylink google Add Al Jazeera on Google info A bottle of Johnson and Johnson Baby Powder [File: Mike Segar/Reuters] By Reuters Published On 28 Jul 2026 28 Jul 2026 Johnson & Johnson (J&J) has agreed to pay $5.5bn to settle tens of thousands of lawsuits in the United States that allege its discontinued talc-based baby powder caused ovarian cancer.
The pharmaceutical giant made the announcement on Monday, saying it covers about 69,000 cases in US federal and state courts, accounting for 99.75 percent of outstanding talc-related cases in the country.
The settlement will only be final once it is accepted by 95 percent of the claimants in state or federal courts.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in